YUNNAN QIDAN PHARMACEUTICAL

What YUNNAN QIDAN PHARMACEUTICAL does

Yunnan Qidan Pharmaceutical Co., Ltd. (云南七丹药业股份有限公司), founded in March 2008 and headquartered in Wenshan, Yunnan Province, is a publicly listed (NEEQ, stock code 832955) full-industry-chain Sanqi (Panax notoginseng) enterprise with registered capital of 99.78 million yuan and an employee base reported in the 11-50 range. The company operates six integrated business lines across TCM decoction pieces (freeze-dried Sanqi, Sanqi powders, and ultrafine powders), health foods (Sanqi extract soft capsules, Sanqi capsules, Sanqi Gegen capsules, Sanqi health wine), foods (fresh Sanqi juice, Sanqi drinks, medicated cakes and pastes), daily chemicals (Sanqi plant toothpaste, foot bath packages, oral sprays, facial masks), Chinese medicine extracts, and quality raw materials — totaling nearly 100 product specifications. Its core technology stack centers on Sanqi GAP digital planting with IoT/big-data traceability, -45°C vacuum freeze-drying (up to 200 tons/year), low-temperature superfine airflow crushing to 1200 mesh, soil fumigation that compresses replanting cycles from 15-20 years to 3-5 years, forest understory organic cultivation following academician Zhu Youyong's model, and a proprietary one-step gel encapsulation process for soft capsules.

The company monetizes through a multi-channel go-to-market approach: direct-to-consumer e-commerce on JD.com and Tmall with a dedicated livestream division, company-operated physical stores (including the Xishuangbanna branch and specialty stores in Qidu Ancient Town), pharmaceutical chain partnerships (e.g., Shuyu Pingmin), regional distributors covering all 30 Chinese provinces, B2B supply of raw materials and extracts to pharmaceutical manufacturers (e.g., Wuzhou Pharmaceutical, Yangtze River Pharmaceutical, Xiuzheng Group, Kunming Pharmaceutical Group), international exports to Singapore, Russia, South Korea, and Japan, and AAA-rated industrial tourism at the Sanqi Cultural Industrial Park. The customer base spans individual healthcare consumers seeking cardiovascular and wellness products, pharmaceutical and health product manufacturers requiring traceable Sanqi raw materials and OEM/ODM services, retail chains and supermarkets seeking differentiated natural health SKUs, hospitals and pharmacy chains requiring GMP-certified decoction pieces, and tourism/cultural visitors. Pricing is quotation-based across B2B and B2C channels with no public price list.

Name

YUNNAN QIDAN PHARMACEUTICAL

Legal name

云南七丹药业股份有限公司

Website

https://wsqidan.com

Company type

Public

Founded year

2008

Operating status

Operating

Headcount range

11–50 employees

Short description

Yunnan Qidan Pharmaceutical is an NEEQ-listed full-industry-chain Sanqi (Panax notoginseng) enterprise based in Wenshan, Yunnan, producing TCM decoction pieces, health foods, foods, daily chemicals, and extracts for individual consumers, pharmacy chains, pharmaceutical manufacturers, and export markets across China and parts of Asia.

Ownership category

akta.pro rank

Headquarters

HQ city

Yünnan

HQ country

China

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Traditional Chinese Medicine Decoction Pieces (中药饮片): Production and sales of freeze-dried Sanqi, Sanqi powder, Sanqi ultrafine powder, cooked Sanqi powder, and other traditional Chinese medicine decoction pieces. These are GMP-certified pharmaceutical products sold primarily through pharmacies and hospitals.
2. Health Food /保健食品: Sales of SFDA-approved blue-cap health food products including Sanqi extract soft capsules, Sanqi capsules, Sanqi aloe capsules, Sanqi Gegen capsules, Weili capsules, and Sanqi health wine. These are sold through pharmacy chains, e-commerce, and distribution networks.
3. Food Products / 食品: Sales of food-grade products including organic fresh Sanqi juice (鲜三七原浆), Sanqi drinks, Sanqi skincare beauty food, and other food items. Products include糕点, 固体饮料, 口服液 lines.
4. Daily Chemical Products / 日化用品: Sales of Sanqi plant toothpaste, Sanqi foot bath packages, Sanqi flower oral spray, Sanqi red seed facial masks, and other daily-use personal care products.
5. Chinese Medicine Extracts / 中药材提取物: Production and B2B sales of Sanqi raw material extracts and active ingredients to pharmaceutical and health product manufacturers.
6. Industrial Tourism and Cultural Experience / 工业旅游与文旅: The company operates the national AAA-rated Sanqi Cultural Industrial Park offering guided tours, Sanqi specialty restaurant, meeting/event venues, and merchandise sales.

Pricing tiers

Go-to-market motion3 records

Distribution channels7 records

Marketing channels7 records

Core offering

Yunnan Qidan Pharmaceutical manufactures and sells Sanqi (Panax notoginseng / 三七)-based products across six categories: traditional Chinese medicine (TCM) decoction pieces, health food, food, daily chemical products, Sanqi extracts, and raw materials, with approximately 100 distinct product specifications. The company operates a vertically integrated production system covering GAP-standard Sanqi cultivation, processing, quality testing, and finished-product manufacturing.

Differentiator

Problem solved

Functional benefit

Products and services

• Sanqi (Panax notoginseng / 三七) TCM Decoction Pieces Traditional Chinese medicine decoction pieces manufactured from Sanqi (Panax notoginseng) and related herbal raw materials, processed and quality-tested at Qidan's facilities, sold to distributors, pharmacy chains, and TCM practitioners. Category includes raw and prepared Sanqi decoction pieces and related herbal pieces.
• Sanqi Health-Food Series (capsules and health wine) Health-food products formulated from Sanqi extracts and complementary herbal ingredients (e.g., Sanqi capsules, Sanqi-based compound capsules such as Sanqi Gegen / Kudzu and Sanqi aloe formulas, Weili capsules, and Sanqi health wine). Sold as consumer health supplements via Qidan's retail stores, pharmacy chains, and e-commerce platforms.
• Sanqi Daily Chemical Products Personal-care and daily-use items incorporating Sanqi or related herbal extracts, including Sanqi toothpaste, foot-bath products, oral-care sprays, and herbal face masks. Sold to end consumers through retail stores and e-commerce channels.
• Sanqi Extracts and Raw Materials Industrial Sanqi extracts and standardized raw materials supplied to pharmaceutical and health-product manufacturers as B2B ingredients. Sold primarily to other manufacturers and wholesalers requiring traceable, quality-certified Sanqi inputs.
• Medicinal-Edible (药食同源) Sanqi Food Series Food-grade products positioned in the medicinal-edible / 药食同源 category, derived from Sanqi and complementary food ingredients. Sold to end consumers via retail stores and online channels.

Quantifiable outcome

• Total saponin content of Sanqi ultrafine powder reaches 10%, significantly higher than the national standard
• +4 more outcomes

Named customers9 records

Segments5 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

22 partnerships are on record, tiered strategic, core and minor.

• 云南文山为了你健康药房有限公司 (Yunnan Wenshan 'For Your Health' Pharmacy Co., Ltd.)strategicChannel Partner/ Reseller/ Distributor · 29 May 2026Tripartite cooperation model with Wen Shan Media Center to build 'industry channel + media channel' coordinated development. The partnership focuses on product supply, channel expansion, and brand empowerment for Sanqi health products including the Sanqi plant toothpaste series.
• 中康民泰集团 (Zhongkang Mintai Group)coreStrategic or Co-development Partner · 24 April 2026Zhongkang Mintai Group (including Zhongkang Mintai Strategic Investment Department President Fan Xiaojian, Hainan Huasen Health GM Liu Libo, Huasen Pharmaceutical GM Li Yong) visited the company for exchange. Both parties explored Sanqi product cooperation opportunities, with the company showcasing its full-industry chain layout, core technology R&D achievements, and diversified product matrix.
• 湖北蕲艾科技集团有限公司 / 蕲艾集团 (Hubei Qiai Technology Group Co., Ltd.)strategicStrategic or Co-development Partner · 14 April 2026Based in 'China's Ai City' (Qichun), the group deeply cultivates the Qiai (Artemisia argyi) full industry chain, integrating planting R&D, production, and terminal chains. Liuding Huixin facilitates cooperation between Qiai Group and Qidan to support the strategic partnership.
• 云南三七科技有限公司 (Yunnan Sanqi Technology Co., Ltd.)coreStrategic or Co-development Partner · 7 April 2026Yunnan Sanqi Technology party secretary and chairman Liu Heng visited the company with Yunnan Teanla Pharmaceutical to discuss cooperation. As the Sanqi industry leader, Sanqi Technology has supported Qidan for many years.
• 广西梧州制药（集团）股份有限公司 (Guangxi Wuzhou Pharmaceutical Group)coreStrategic or Co-development Partner · 26 March 2026Long-term strategic partner in TCM healthcare. Wuzhou Pharmaceutical and Qidan have established a stable, deeply mutual-trusting strategic cooperative relationship. Wuzhou Pharmaceutical VP Mai Zhixiong led a team to visit GAP种植 base and understand the company's full-chain layout from source planting to deep processing.
• 武汉六鼎汇鑫商贸有限公司 (Wuhan Liuding Huixin Trading Co., Ltd.)coreStrategic or Co-development Partner · 29 January 2026Key strategic partner for market development. A joint investment promotion ceremony was held in Wuhan. The partnership focuses on Sanqi health product channel co-building, with both parties committed to bringing Wenshan Sanqi to households across China. The company cooperates with Liuding on product distribution, marketing support, and brand promotion.
• 中国医药物资协会 (China Medical Pharmaceutical Materials Association)strategicGTM or Marketing Partner · 26 November 2025The company was elected as a vice-president unit of the association and chairman Yang Chaowen was appointed as a vice-president. The association has nearly 6,000 member units covering pharmaceutical industry, retail, health products, cosmetics, food, logistics, and other sectors.
• 文山州融媒体中心 (Wen Shan Prefecture Media Center)coreGTM or Marketing Partner · 12 November 2025Strategic media partnership for comprehensive brand promotion. The media center leverages all-media communication advantages to help the company enhance brand visibility and market recognition. Both parties signed a strategic cooperation agreement to develop coordinated brand promotion activities.
• 扬子江药业集团有限公司 (Yangtze River Pharmaceutical Group)strategicStrategic or Co-development Partner · 21 October 2025Yangtze River Pharmaceutical Group's chairman Xu Haoyu led a delegation to visit the company during the South Asia Expo period, exploring Sanqi industry cooperation opportunities. The company briefed the delegation on its Sanqi industry development and product innovation achievements.
• 文山州农业科学院 (Wen Shan Prefecture Academy of Agricultural Sciences)strategicStrategic or Co-development Partner · 17 October 2025Joint party-building activity and cooperation on Sanqi breeding, understory Sanqi cultivation key technology research, germplasm resource collection and identification, modern biological breeding technology breakthroughs, and green cultivation technology R&D.
• 西双版纳州相关旅游渠道 (Xishuangbanna Tourism Channels)strategicChannel Partner/ Reseller/ Distributor · 31 August 2025The company opened a retail branch in Xishuangbanna to extend its presence into the tourism retail market, selling Sanqi health products to tourists visiting the area.
• 滇商总会 (Dian Merchant Association)minorGTM or Marketing Partner · 26 July 2025The company received the '时代滇商·2025最具商业创新模式单位' award at the 2025 Global Dian Merchant Development Summit organized by the Dian Merchant Association.
• 修正集团 (Xiuzheng Group)strategicStrategic or Co-development Partner · 6 July 2025Xiuzheng Group chairman Xiu Laigui led a team to visit the company to explore Sanqi industry cooperation opportunities. The visit enhanced mutual understanding between the two companies.
• 中国驻越南企业家代表团 (Chinese Entrepreneurs Delegation to Vietnam)strategicGTM or Marketing Partner · 21 June 2025A delegation of Chinese enterprises based in Vietnam visited the company to discuss cross-border cooperation on Sanqi products, including product localization, supply chain cooperation, and brand promotion in the Vietnamese market. The company reported that some Sanqi products are already exported to Singapore and discussions focused on expanding to the broader Southeast Asian market.
• 云南师范大学 (Yunnan Normal University)minorStrategic or Co-development Partner · 1 June 2023The company co-built a teaching practice and employment base with Yunnan Normal University, providing students with practical training opportunities in the Sanqi industry.
• 杭州胡庆余堂、浙江英特医药药材、杭州民泰中药饮片等 (Hangzhou Hu Qing Yu Tang, Zhejiang Yite Medical Materials, Hangzhou Mintai TCM Decoction Pieces, etc.)strategicChannel Partner/ Reseller/ Distributor · 1 January 2023A Hangzhou government-business delegation including these well-known TCM companies visited the company to explore Sanqi supply chain cooperation and market expansion opportunities.
• 漱玉平民大药房连锁股份有限公司 (Shuyu Pingmin Pharmacy Chain Co., Ltd.)coreChannel Partner/ Reseller/ Distributor · 1 January 2023Shuyu Pingmin is a major pharmacy chain partner. The company's VP Zhang Hua and TCM division GM Sun Lina visited for exchange on high-quality Sanqi industry development and health product channel co-building.
• 云南省农业科学院 (Yunnan Academy of Agricultural Sciences)strategicStrategic or Co-development Partner · 1 January 2022Academic leader Zhu Youyong's team collaborated on understory Sanqi cultivation demonstration and promotion, enabling forest-based organic cultivation without chemical pesticides.
• 昆明理工大学 (Kunming University of Science and Technology)coreStrategic or Co-development Partner · 1 January 2011Long-term research collaboration partner. The company and KUST jointly completed multiple provincial and national science and technology projects, including the 2025 China Commerce Federation Science and Technology Progress Special Award project. Researcher Cui Xiuming (崔秀明) leads the joint research team.
• 文山学院 (Wenshan University)coreStrategic or Co-development Partner · 1 January 2011Long-term research and talent cultivation partner. The company cooperates with Wenshan University's Sanqi Medical College on talent cultivation, R&D, and technology transfer. The company also provides lectures at the university by its technical staff.
• 上海中医药大学 (Shanghai University of Traditional Chinese Medicine)strategicStrategic or Co-development Partner · 1 January 2011Long-term research collaboration with the university's elderly medicine research institute for Sanqi product R&D and health applications.
• 云南省崔秀明专家基层科研工作站 (Yunnan Cui Xiuming Expert Grassroots Research Workstation)coreStrategic or Co-development Partner · 1 January 2011Provincial expert workstation collaborating on Sanqi cultivation technology, GAP standardization, and processing technology research.

Scale indicators12 records

Recent moves10 records

Expansion highlights6 records

Direct peers

• Yunnan Baiyao Group: Yunnan-based TCM conglomerate and listed toothpaste/consumer health products manufacturer. Direct comparable because both are Yunnan-rooted herbal medicine companies with branded Sanqi-related health products and a toothpaste line, sharing overlapping retail pharmacy channels and consumer target markets.
• Yunnan Sanqi Technology Co., Ltd. Sanqi industry leader named in Qidan's own partnership records. Direct comparable because it operates in the same Panax notoginseng value chain with competing GAP planting and processing operations, targeting the same B2B pharmaceutical extract buyers and health-food formulators.
• Kunming Pharmaceutical Group: Disclosed strategic research partner on Qidan's Sanqi cultivation/processing standards project. Comparable because it is a Yunnan-headquartered TCM manufacturer that sources Sanqi raw materials and extracts, and shares the same regional supplier ecosystem and Yunnan provincial regulatory environment.
• Guangxi Wuzhou Pharmaceutical Group: Disclosed long-term strategic TCM healthcare partner that sources from Qidan's full chain. Comparable as a regional TCM manufacturer using Sanqi-based formulations across its中药 product lines, sharing the same B2B raw material and TCM decoction piece markets.

Broad incumbents

• Tongrentang: China's most established traditional Chinese medicine brand with national retail pharmacy presence. Comparable as a broad incumbent in the TCM category serving similar health-conscious consumer and pharmacy channel customers, though it operates a much wider portfolio of herbal products.
• Pien Tze Huang: Listed Fujian-based TCM manufacturer famous for premium branded herbal formulations. Comparable as a broad incumbent in the branded TCM/Chinese medicine preparation segment with similar health-positioning consumers and pharmacy distribution channels.
• China TCM Holdings: Hong Kong-listed TCM conglomerate with中药配方颗粒 (TCM granule) and中药饮片 (decoction pieces) product lines. Comparable because it operates in Qidan's core decoction pieces and TCM raw material processing segments at much larger scale across China.
• Guangzhou Pharmaceutical Holdings: One of China's largest state-owned TCM and pharmaceutical groups with extensive中药饮片 and branded health product operations. Comparable as a broad incumbent serving overlapping pharmacy retail and consumer health channels.
• Hutchison China MediTech (Hutchmed): Hong Kong-listed pharma group with both innovative drug and TCM/consumer health businesses. Comparable as a broader incumbent in the Chinese pharma + TCM consumer health space, with similar end-market exposure to Chinese health-conscious consumers.

Emerging players

• Shandong Taiyue Biotechnology Group: Disclosed partner on the 'Red Heart Pulse' cardiovascular health initiative in Qidan's data. Comparable as an emerging player in the botanical health product space, collaborating on Sanqi-based cardiovascular formulations for similar consumer use cases.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about YUNNAN QIDAN PHARMACEUTICAL